Silagene

Early-stage cancer therapeutics discovery company developing gene silencing technologies

placeHillsborough, New Jersey, United States calendar_todayFounded 2008 language silagene.com

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 178 times.

YearFilings
20131
20152
20161
20202
20212
20222

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon